- Recent Advances in Anti-Obesity Drugs
-
Son JW
- KMID: 2531495
- J Korean Diabetes.
- 2022 Jun;23(2):113-127.
- doi: 10.4093/jkd.2022.23.2.113
Obesity is a chronic, complex, and heterogeneous disease that is affected by genetic, developmental, biological, and environmental factors; thus, it is necessary to approach obesity with an integrated and comprehensive... -
- CITED
-
- Close
- SHARE
-
- Close
- Recent Updates of Pharmacotherapy for Smoking Cessation
-
Hwang JS, Lee CM
- KMID: 2523463
- Korean J Fam Pract.
- 2021 Dec;11(6):403-414.
- doi: 10.21215/kjfp.2021.11.6.403
The use of tobacco, cigarette smoking in particular, is a leading causal factor of countless deaths and disabilities worldwide. Its widespread prevalence is a major global concern and is evidenced... -
- CITED
-
- Close
- SHARE
-
- Close
- A Literature Review on the Efficacy and Related Neural Effects of Pharmacological and Psychosocial Treatments in Individuals With Internet Gaming Disorder
-
Seo EH, Yang HJ, Kim SG, Park SC, Lee SK, Yoon HJ
- KMID: 2523445
- Psychiatry Investig.
- 2021 Dec;18(12):1149-1163.
- doi: 10.30773/pi.2021.0207
Objective Internet gaming disorder (IGD) has attracted considerable attention as a serious mental and public health issue worldwide. Currently, there are no established treatment guidelines for IGD. Herein, we review... -
- CITED
-
- Close
- SHARE
-
- Close
- Anti-Obesity Drugs: Long-Term Efficacy and Safety: An Updated Review
-
Tak YJ, Lee SY
- KMID: 2513972
- World J Mens Health.
- 2021 Apr;39(2):208-221.
- doi: 10.5534/wjmh.200010
As a chronic and relapsing disease, obesity negatiⓇvely impacts the health of men to a greater extent than that of women, with a higher risk of cardiovascular disease. Since lifestyle... -
- CITED
-
- Close
- SHARE
-
- Close
- Comprehensive Review of Current and Upcoming Anti-Obesity Drugs
-
Son JW, Kim S
- KMID: 2513044
- Diabetes Metab J.
- 2020 Dec;44(6):802-818.
- doi: 10.4093/dmj.2020.0258
Obesity is among the leading causes of morbidity and mortality worldwide and its prevalence continues to increase globally. Because obesity is a chronic, complex, and heterogeneous disease influenced by genetic,... -
- CITED
-
- Close
- SHARE
-
- Close
- Bupropion overdose as a clinically significant confounder of the neurological examination
-
Reyes R, Figueroa S
- KMID: 2509941
- J Neurocrit Care.
- 2020 Dec;13(2):109-114.
- doi: 10.18700/jnc.200021
Background: Bupropion is a selective dopamine and norepinephrine reuptake inhibitor utilized in the treatment of multiple neuropsychiatric conditions. It has been implicated as a brain death mimic due to its... -
- CITED
-
- Close
- SHARE
-
- Close
- Bupropion/Naltrexone (CONTRAVE ®)-induced Acute Generalized Exanthematous Pustulosis
-
Kim YS, Lee JH, Choi JE, Han TY
- KMID: 2505574
- Korean J Dermatol.
- 2020 Aug;58(7):502-504.
-
- CITED
-
- Close
- SHARE
-
- Close
- Current Long-Term Pharmacotherapies for the Management of Obesity
-
Kim BY, Kang SM, Kang JH, Kim KK, Kim B, Kim SJ, Kim YH, Kim JH, Kim JH, Nam GE, Park JY, Son JW, Shin HJ, Oh TJ, Lee H, Jeon EJ, Chung S, Hong YH, Kim CH, Committee of Clinical Practice Guidelines, Korean Society for the Study of Obesity (KSSO)
- KMID: 2503838
- J Obes Metab Syndr.
- 2020 Jun;29(2):99-109.
- doi: 10.7570/jomes20010
Obesity is a serious and growing worldwide health challenge associated with type 2 diabetes mellitus, cardiovascular disease, osteoarthritis, some cancers, sleep apnea, asthma, and nonalcoholic fatty liver. The Korean Society... -
- CITED
-
- Close
- SHARE
-
- Close
- Long-Term Current Management of Enduring Obesity in Diabetes
-
Kim CH
- KMID: 2506770
- J Korean Diabetes.
- 2020 Mar;21(1):21-26.
- doi: 10.4093/jkd.2020.21.1.21
Obesity increases the risk of diabetes, hypertension, and cardiovascular diseases, ultimately contributing to mortality. The Korean Society for the Study of Obesity (KSSO) was established to improve the management of... -
- CITED
-
- Close
- SHARE
-
- Close
- Effectiveness and Safety of Bupropion in Children and Adolescents with Depressive Disorders: A Retrospective Chart Review
-
Kweon K, Kim HW
- KMID: 2464721
- Clin Psychopharmacol Neurosci.
- 2019 Nov;17(4):537-541.
- doi: 10.9758/cpn.2019.17.4.537
OBJECTIVE: This study aimed to investigate the effectiveness and safety of bupropion extended-release for the treatment of depressive disorder in children and adolescents. METHODS: This was a 12-week, retrospective chart review... -
- CITED
-
- Close
- SHARE
-
- Close
- Augmentation of Aripiprazole versus Bupropion on Specific Symptoms of Depression in Older Adult Patients : A Post-Hoc, Multi-Center, Open-Label, Randomized Study
-
Jo S, Cheon E, Lee K, Koo B, Park Y, Lee J, Lee S, Sung H
- KMID: 2454245
- J Korean Soc Biol Ther Psychiatry.
- 2019 Jun;25(2):138-151.
- doi: 10.0000/jksbtp.2019.25.2.138
OBJECTIVES: The purpose of this study was to compare aripiprazole versus bupropion augmentation therapy in older adult patients with major depressive disorder unresponsive to selective serotonin reuptake inhibitors(SSRIs). METHODS: This is... -
- CITED
-
- Close
- SHARE
-
- Close
- Metoprolol treatment of dual cocaine and bupropion cardiovascular and central nervous system toxicity
-
Richards J, Gould JB, Laurin EG, Albertson
- KMID: 2447313
- Clin Exp Emerg Med.
- 2019 Mar;6(1):84-88.
- doi: 10.15441/ceem.17.247
Cardiovascular and central nervous system (CNS) toxicity, including tachydysrhythmia, agitation, and seizures, may arise from cocaine or bupropion use. We report acute toxicity from the concomitant use of cocaine and... -
- CITED
-
- Close
- SHARE
-
- Close
- Understanding the Mechanism of Action and Clinical Implications of Anti-Obesity Drugs Recently Approved in Korea
-
Kim KK
- KMID: 2447082
- Korean J Fam Med.
- 2019 Mar;40(2):63-71.
- doi: 10.4082/kjfm.19.0013
The Korean Ministry of Food and Drug Safety has approved three anti-obesity drugs for long-term management in the past decade. In addition, since 2019, bariatric surgery has been financially supported... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of the Bupropion versus Aripiprazole Adjunctive Therapy for the Treatment of Female Depression : Post-Hoc Analyses from a Randomized Prospective Open-Label Multi-Center Study
-
Keum MS, Cheon EJ, Lee KH, Koo BH, Lee YJ, Park YW, Lee JH, Lee SJ, Sung HM
- KMID: 2434871
- Mood Emot.
- 2018 Nov;16(3):140-151.
- doi: 10.0000/me.2018.16.3.140
OBJECTIVES: The purpose of this study was to examine effects of adjunctive aripiprazole versus bupropion, on depressive symptoms of female depression. METHODS: Sixty six female patients with major depressive disorders were... -
- CITED
-
- Close
- SHARE
-
- Close
- National Trends in Smoking Cessation Medication Prescriptions for Smokers With Chronic Obstructive Pulmonary Disease in the United States, 2007-2012
-
Kwak MJ, Kim J, Bhise V, Chung TH, Petitto GS
- KMID: 2424399
- J Prev Med Public Health.
- 2018 Sep;51(5):257-262.
- doi: 10.3961/jpmph.18.119
OBJECTIVES: Smoking cessation decreases morbidity and mortality due to chronic obstructive pulmonary disease (COPD). Pharmacotherapy for smoking cessation is highly effective. However, the optimal prescription rate of smoking cessation medications... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparing the Effects of Bupropion and Escitalopram on Excessive Internet Game Play in Patients with Major Depressive Disorder
-
Nam B, Bae S, Kim SM, Hong JS, Han DH
- KMID: 2396307
- Clin Psychopharmacol Neurosci.
- 2017 Nov;15(4):361-368.
- doi: 10.9758/cpn.2017.15.4.361
OBJECTIVE: Several studies have suggested the efficacy of bupropion and escitalopram on reducing the excessive internet game play. We hypothesized that both bupropion and escitalopram would be effective on reducing... -
- CITED
-
- Close
- SHARE
-
- Close
- Tardive Dyskinesia Associated with Bupropion
-
Tuman TC, Çakır U, Yıldırım O, Camkurt MA
- KMID: 2378492
- Clin Psychopharmacol Neurosci.
- 2017 May;15(2):194-196.
- doi: 10.9758/cpn.2017.15.2.194
Present report describes a 46 year old male patient with a diagnosis of major depression who developed tardive dyskinesia during bupropion therapy. Our patient had no history of neuroleptic use... -
- CITED
-
- Close
- SHARE
-
- Close
- The Accompanying Changes in Brain Structure of a Remitted Depression Patient with the Bupropion Treatment
-
Hou YC, Lai CH
- KMID: 2171036
- Clin Psychopharmacol Neurosci.
- 2015 Dec;13(3):319-320.
- doi: 10.9758/cpn.2015.13.3.319
The impacts from the bupropion on the brain structures have seldom been mentioned in the literature. The bupropion is a kind of antidepressant with dual action in the norepinephrine and... -
- CITED
-
- Close
- SHARE
-
- Close
- Safety of Anti-Obesity Drugs Approved for Long-Term Use
-
Kim KK
- KMID: 2271148
- Korean J Obes.
- 2015 Mar;24(1):17-27.
- doi: 10.7570/kjo.2015.24.1.17
Because of the widespread use of ant-obesity medications, bariatricians need to be aware not only of common adverse events but also uncommon serious events in the pharmacotherapy of obesity. Safety... -
- CITED
-
- Close
- SHARE
-
- Close
- Bupropion for Interferon-Alpha-Induced Depression in Patients with Hepatitis C Viral Infection: An Open-Label Study
-
Chen WC, Lai HC, Su WP, Palani M, Su KP
- KMID: 2316400
- Psychiatry Investig.
- 2015 Jan;12(1):142-145.
- doi: 10.4306/pi.2015.12.1.142
Interferon (IFN)-alpha therapy for chronic hepatitis C virus (HCV) infection is frequently associated with major depressive episodes. Bupropion, a commonly used antidepressant agent, has recently found to have strong anti-inflammatory... -
- CITED
-
- Close
- SHARE
-
- Close
